Global Blotting Systems Market 2017-2021
About Blotting Systems
Blotting system is used for the detection of nucleic acids or proteins from specific tissue or cell samples. Blotting systems are an essential part of any molecular diagnostic procedure and the basis for analysis in the application of molecular diagnosis to obtain greater results. Molecular diagnostics refer to a set of defined techniques that analyze biological markers in the genome and proteome to diagnose medical conditions or to study genetic differences.
Technavio’s analysts forecast the global blotting systems market to grow at a CAGR of 4.83% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global blotting systems market for 2017-2021. To calculate the market size, the report considers sales of blotting systems in the market.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Blotting Systems Market 2017-2021
Technavio recognizes the following companies as the key players in the global blotting systems market: Bio-Rad Laboratories, GE Healthcare, Merck Millipore, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: Abcam, Advansta, AMRESCO, Azure Biosystems, Cell Signaling Technology, Cygnus Technologies, KOMABIOTECH, SeraCare, LI-COR, Lumigen, PerkinElmer, ProteinSimple, and Rockland Immunochemicals.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is technological advances. Over the years, blotting systems have undergone significant changes to make the test more effective. Many companies across the world have invented technologies that ensure high accuracy in the products they offer.”
According to the report, one driver in the market is increased use in proteomics. The field of proteomics includes the study of all proteins produced by an individual as the prime area for characterization and identification of proteins. The characterization of proteins is difficult because many proteins are produced by the same gene, and chemical structure of a protein is more diverse, making its sequencing and identification more difficult.
Further, the report states that one challenge in the market is need for skilled professionals. The various methods of blotting are complex in nature and require a thorough understanding of the procedure for effective use. Only skilled professionals can easily transfer the nucleic acids or proteins from the fragile gel to the membrane. Non-skilled persons can face difficulty in carrying out these procedures. Hence, adequate training of professionals is required to obtain an accurate result.
Bio-Rad Laboratories, GE Healthcare, Merck Millipore, Thermo Fisher Scientific, Abcam, Advansta, AMRESCO, Azure Biosystems, Cell Signaling Technology, Cygnus Technologies, KOMABIOTECH, SeraCare, LI-COR, Lumigen, PerkinElmer, ProteinSimple, and Rockland Immunochemicals.